Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer (10X Multiome)
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 22 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 22 samples: 11 × CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, vs 11 × CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Cytotoxic CD39(+) tumor-associated NK cells respond to NKG2A blockade in lung cancerScience immunology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE304741_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1302431. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 22 samples.
How we read this: 2 replicated groups read from 22 sample titles; they account for 22 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9156070 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 1 CD56⁺ NK and T cells so…
- GSM9156071 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 1 CD56⁺ NK and T cells so…
- GSM9156072 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 2 CD56⁺ NK and T cells so…
- GSM9156073 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 2 CD56⁺ NK and T cells so…
- GSM9156074 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 3 CD56⁺ NK and T cells so…
- GSM9156075 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 3 CD56⁺ NK and T cells so…
- GSM9156076 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 4 CD56⁺ NK and T cells so…
- GSM9156077 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 4 CD56⁺ NK and T cells so…
- GSM9156078 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 5 CD56⁺ NK and T cells so…
- GSM9156079 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 5 CD56⁺ NK and T cells so…
- GSM9156080 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 6 CD56⁺ NK and T cells so…
- GSM9156081 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 6 CD56⁺ NK and T cells so…
- GSM9156082 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 7 CD56⁺ NK and T cells so…
- GSM9156083 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 7 CD56⁺ NK and T cells so…
- GSM9156084 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 8 CD56⁺ NK and T cells so…
- GSM9156085 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 8 CD56⁺ NK and T cells so…
- GSM9156086 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 9 CD56⁺ NK and T cells so…
- GSM9156087 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 9 CD56⁺ NK and T cells so…
- GSM9156088 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 10 CD56⁺ NK and T cells so…
- GSM9156089 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 10 CD56⁺ NK and T cells so…
- GSM9156090 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, GEX, rep 11 CD56⁺ NK and T cells so…
- GSM9156091 CD56⁺ NK and T cells sorted from treatment-naive NSCLC, ATAC, rep 11 CD56⁺ NK and T cells so…
- GSE319755 Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer (10x Xenium) 3 samples shares nkg2a, cd39, 10x, tumor-associated, cytotoxic, blockade, respond
- GSE334763 Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer 25 samples shares nkg2a, cd39, tumor-associated, cytotoxic, blockade, respond
- GSE244585 Single nuclei chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry [10X single-cell multiome] 32 samples shares 10x, multiome
- GSE274113 Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes [10x ATAC + GEX Multiome] 42 samples shares 10x, multiome
- GSE277326 Single-cell analysis of the epigenome and 3D chromatin architecture in the human retina [10x multiome] 18 samples shares 10x, multiome
- GSE314298 NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors 2 samples shares nkg2a, cytotoxic
- GSE293273 10X sc-multiome data of NCIH2170 cell line 2 samples shares 10x, multiome
- GSE263178 Bone Marrow Stromal Cells Induce Chromatin Remodeling in Multiple Myeloma Cells Leading to Transcriptional Changes [Multiome (10X Genomics) - scRNA-Seq & scATAC-Seq] 2 samples shares 10x, multiome
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.